Here you find a selection of projects which have been personally realized by our project leading partners at Jürg Kurmann Mergers & Acquisitions AG or in previous positions.
Structuring of important price optimizing financial definitions in connection with closing accounts items at the sale to the NYSE-listed Luxoft.
Systematic target research in German speaking Switzerland. Initiating and supporting the negotiations in a leading role, structuring the transaction and support of the transaction process until completion of the acquisition of 100% of the share capital of Tiro Personal AG, Zürich.
Sale of the loss-making and substantially contingent liabilities burdened Bedag Gemeinden Informatik AG via several intermediate steps, including participation on the Board.
Identification of the transaction opportunity and advice to the buyer in the negotiations to acquire in an asset deal product rights and the global distribution rights of human OTC products.
Competitive company sale project. Selling to the German Troester-Gruppe.
Support of the Board of Directors of Trans-Data Management AG in executive management. Lead in the sale of a controlling interest to Hadorn Industries AG.
Global «360 degree» search- and buy-project. Identification of the Irish Allergy Standards Ltd. with a in the USA leading label for allergy and asthma-friendly consumer goods and completion of a participation-based strategic partnership.
Design of the corporate governance; Development of the ownership strategy for the significant commercial blood fractionation business (ZLB) and coaching of the process for the decision to divest which was then carried out by an investment bank.
Review of all direct investments. Joining the Board of Kieser Training AG and sale of the minority participation to majority shareholders Mr. and Mrs. Kieser.
Active roles as Chairman of the Board of Directors, CEO and liquidator. Sale of the operative business to the German Biofibre GmbH. Auctioning of the production facilities.
Global «360 degree» search- and buy project. On-site target evaluation in the USA, China, Italy, Germany and Switzerland.
Realization of succession solution concurrently with a growth financing for the company. Sale in two steps to the Italian Pierrel Pharmaceutici S.p.A.